Analysis

COMPANY

Services

Account

Highlights

Nike Defends Its Trademark Stronghold While Navigating Strategic Delays and Market Pressures

Jun/23/2025

Nike has mounted legal opposition against the trademark application for 'NIUSHOX', arguing its confusing similarity to the company’s well-established 'NIKE SHOX' mark in the overlapping category of footwear and related products, including socks and sport stockings. This trademark defense unfolds against the backdrop of broader corporate maneuvering, as the sportswear giant grapples with delays in the much-anticipated NikeSkims launch, its high-profile partnership with Kim Kardashian’s Skims brand. Initially slated for a spring debut, the collection—aimed at fusing style and performance for the women’s market—has been postponed until later this year due to production hurdles. Meanwhile, new CEO Elliott Hill is steering Nike through a delicate turnaround, balancing efforts to rekindle wholesale partnerships, rightsize bloated franchises like Jordan and Dunk, and absorb the impact of recent price hikes and tariff risks. Analysts remain cautious: revenue fell 9% last quarter, and while core lines like Air Force 1 have shown promotional resilience, demand challenges persist elsewhere.

S&P Pushes Back on ‘Fortune 500’ Trademark Amid Index Turf Battle

Jun/16/2025

Standard & Poor’s Financial Services lodged a formal opposition on June 13 against FORTUNE MEDIA IP LIMITED’s attempt to trademark 'FORTUNE 500' for a suite of financial indexing and analysis services. S&P contends that the mark infringes upon its well-established 'S&P 500' family of trademarks—flagship indices synonymous with market benchmarks—arguing not only phonetic similarity but also functional overlap across international classes 35 and 36. This legal maneuver underscores S&P’s intent to safeguard its brand identity in an increasingly crowded financial data landscape. The opposition comes as trademark policing becomes more technologically sophisticated, with tools like the Trademark Watchdog app providing automated detection of naming conflicts and industry class intersections, streamlining enforcement for rights holders and counsel alike. Following tag cloud shows portfolio trademarks of Standard & Poor’s Financial Services with relating classes.

Unilever Expands Premium Grooming Playbook with 'SCALPCEUTICALS' Trademark and Dr. Squatch Acquisition

Jun/24/2025

Unilever has sharpened its focus on high-growth personal care segments, filing a U.S. trademark for 'SCALPCEUTICALS' on June 11 for an expansive portfolio of grooming and cosmetic products ranging from hair care treatments and skin care preparations to bath essentials and non-medicated toiletries. Following visualization shows detail info on new Unilever 'SCALPCEUTICALS', highlighting the breadth of product categories and the brand’s positioning at the intersection of science-driven hair and scalp care. Simultaneously, the consumer goods giant acquired direct-to-consumer (DTC) grooming brand Dr. Squatch, known for its viral social campaigns and bold, influencer-driven marketing aimed at Gen Z men. This acquisition grants Unilever valuable first-party data and reinforces its push into digital-first, premium verticals— a strategy being accelerated under CEO Fernando Fernandez. As Unilever scales Dr. Squatch internationally, it is doubling down on social and influencer-led engagement, seeking to modernize its portfolio while shedding underperforming units, a playbook that has delivered mixed results in past DTC ventures like Dollar Shave Club.

Eli Lilly Defends Its Trademark Turf While Expanding into Gene Editing

Jun/17/2025

Even as Eli Lilly deepens its foray into cutting-edge cardiovascular therapies—underscored by its recent $1.3 billion acquisition of gene-editing pioneer Verve Therapeutics—the pharmaceutical heavyweight has remained equally assertive in protecting its intellectual property. In four separate rulings from WIPO, Lilly prevailed against domain squatters exploiting its high-profile brands, notably MOUNJARO and ZEPBOUND. The disputed domains — <imounjaroo.life>, <canetamonjaro.site>, <mounjaroku.com>, <lillyzepboundonline.com>, and <mounjaroofficial.com> — were all found to have mimicking Lilly trademarks. Panelists noted the respondents’ repeated use of modifiers such as 'official', 'online', and geographical hints to create an illusion of legitimacy, while directing traffic to sites offering unregulated pharmaceuticals or even rival products. The rulings not only reaffirm Lilly’s global trademark rights but also highlight the reputational and safety risks associated with online drug counterfeiting. As the firm accelerates its ambitions in gene therapies — with Verve’s base - editing platform and its lead PCSK9-targeting candidate VERVE-102 promising a one-time, potentially curative treatment for high cholesterol — its dual strategy of innovation and aggressive brand enforcement underscores the stakes in both reputation management and therapeutic leadership. Analysts suggest the acquisition marks a timely vote of confidence in the gene-editing sector, which has recently faced investor skepticism.

Discover Key Findings and Notable Results

Latest Highlights